LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

Search

Pfizer

Închisă

SectorSănătate

25.49 4.6

Rezumat

Modificarea prețului

24h

Curent

Minim

24.37

Maxim

25.5

Indicatori cheie

By Trading Economics

Venit

623M

3.6B

Vânzări

2B

17B

P/E

Medie Sector

14.18

77.256

EPS

0.87

Randament dividend

6.96

Marjă de profit

21.322

Angajați

81,000

EBITDA

325M

5.6B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+18.71% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

6.96%

2.33%

Data viitoare de dividende

1 dec. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-1.5B

139B

Deschiderea anterioară

20.89

Închiderea anterioară

25.49

Sentimentul știrilor

By Acuity

37%

63%

134 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Pfizer Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 nov. 2025, 13:08 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

10 nov. 2025, 09:41 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk Shares Rise After Withdrawal of Metsera Takeover Battle

10 nov. 2025, 16:35 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Pfizer CEO Confident Metsera Therapies Will Get Approval -- Market Talk

10 nov. 2025, 16:26 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Pfizer CEO: Metsera Has Exciting Weight-Loss Portfolio -- Market Talk

10 nov. 2025, 15:36 UTC

Achiziții, Fuziuni, Preluări

What's Next for Novo Nordisk? -- WSJ

10 nov. 2025, 14:05 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Pfizer Will See Big Benefits from Metsera Acquisition -- Market Talk

10 nov. 2025, 12:33 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 nov. 2025, 12:32 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 nov. 2025, 10:45 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com

10 nov. 2025, 10:34 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, CoreWeave, and More -- Barrons.com

10 nov. 2025, 10:32 UTC

Acțiuni populare

Stocks to Watch Monday: Metsera, Novo Nordisk, Nvidia, Tyson Foods -- WSJ

10 nov. 2025, 09:26 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk Shares Rise After Withdrawal From Metsera Takeover Battle

8 nov. 2025, 13:10 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 nov. 2025, 03:50 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 nov. 2025, 03:41 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 nov. 2025, 03:07 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 nov. 2025, 13:26 UTC

Achiziții, Fuziuni, Preluări

Correction to This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. Article -- WSJ

7 nov. 2025, 10:30 UTC

Achiziții, Fuziuni, Preluări

This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. -- WSJ

6 nov. 2025, 20:02 UTC

Achiziții, Fuziuni, Preluări

Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. -- Barrons.com

6 nov. 2025, 16:16 UTC

Câștiguri

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

6 nov. 2025, 12:29 UTC

Câștiguri

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 nov. 2025, 12:15 UTC

Câștiguri

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 nov. 2025, 00:24 UTC

Achiziții, Fuziuni, Preluări

Metsera: Pfizer Has Reiterated It Will Continue to Litigate >MTSR

6 nov. 2025, 00:24 UTC

Achiziții, Fuziuni, Preluări

Metsera: Board of Directors Will Continue to Stand Firm on Behalf of Shareholders, Patients >MTSR

6 nov. 2025, 00:24 UTC

Achiziții, Fuziuni, Preluări

Metsera: Gratified by Court Decision to Deny Pfizer's Request for Temporary Restraining Order to Block Board From Acting in Shareholders' Best Interests >MTSR

6 nov. 2025, 00:22 UTC

Achiziții, Fuziuni, Preluări

Metsera Issues Statement in Response to Pfizer Litigation Ruling

5 nov. 2025, 22:44 UTC

Achiziții, Fuziuni, Preluări

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 nov. 2025, 22:12 UTC

Achiziții, Fuziuni, Preluări

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 nov. 2025, 22:11 UTC

Achiziții, Fuziuni, Preluări

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 nov. 2025, 22:11 UTC

Achiziții, Fuziuni, Preluări

Pfizer Responds to Delaware Chancery Court Ruling

Comparație

Modificare preț

Pfizer Așteptări

Obiectiv de preț

By TipRanks

18.71% sus

Prognoză pe 12 luni

Medie 29 USD  18.71%

Maxim 34 USD

Minim 24 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPfizer - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

14 ratings

3

Cumpărare

10

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

22.855 / 23.85Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

134 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat